Hydrochloric Acid

Hydrochloric Acid

SCHEMBL1770569

CCCC[P+](CCCC)(CCCC)Cc1ccccn1.[Cl-]

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BDKRB2 known ✓ P30411 4/20 0.49
GRIN2D O15399 1/20 0.42
GRIN3B O60391 1/20 0.42
GRIN1 Q05586 1/20 0.42
GRIN2A Q12879 1/20 0.42
GRIN2B Q13224 1/20 0.42
GRIN2C Q14957 1/20 0.42
GRIN3A Q8TCU5 1/20 0.42
FDPS P14324 1/20 0.41
PTPRA P18433 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41
HRH1 P35367 2/20 0.40
HPGD P15428 1/20 0.40
HSD17B10 Q99714 1/20 0.40
LMNA P02545 1/20 0.40
TAAR1 Q96RJ0 1/20 0.40
ALDH1A1 P00352 1/20 0.40
ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28265189 0.82 GRIN2D (0.46) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL8523869 0.79 GRIN2D (0.44) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL18948136 0.79 GRIN2D (0.44) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL9847091 0.77 FDPS (0.44) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL29058174 0.76 GRIN2D (0.44) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL21078278 0.76 GRIN2D (0.44) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL21770640 0.76 GRIN2D (0.44) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL19732279 0.76 GRIN2D (0.44) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Hydrochloric Acid SCHEMBL4827329 0.76 BDKRB2 (0.46) BDKRB2HSD17B10LMNA
SCHEMBL3256822 0.76 HRH1 (0.49) HRH3HRH1LMNATAAR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2135867-B1 Trans-9, 10-dehydroepothilone C and trans-9, 10-dehydroepothilone D, analogs thereof and methods of making the same KOSAN BIOSCIENCES INC (US) 2013-09-25 EP disclosed
US-20110112149-A1 EPOTHILONE ANALOGUES, THEIR PHARMACEUTICAL COMPOSITIONS, THEIR USE AND THEIR PREPA RATIONS TANG, LI (CN) 2011-05-12 US disclosed
EP-2261221-A1 EPOTHILONE ANALOGUES, THEIR PHARMACEUTICAL COMPOSITIONS, THEIR USE AND THEIR PREPARATIONS Tang, Li (CN) 2010-12-15 EP disclosed
EP-2135867-A1 Trans-9, 10-dehydroepothilone C and trans-9, 10-dehydroepothilone D, analogs thereof and methods of making the same Kosan Biosciences Incorporated (US) 2009-12-23 EP disclosed
EP-1562941-B1 TRANS-9,10-DEHYDROEPOTHILONE C AND D, ANALOGS THEREOF AND METHOS OF MAKING THE SAME KOSAN BIOSCIENCES INC (US) 2009-12-23 EP disclosed
EP-2135868-A1 TRANS-9, 10-DEHYDROEPOTHILONE C AND D, ANALOGS THEREOF AND METHODS OF MAKING THE SAME Kosan Biosciences Incorporated (US) 2009-12-23 EP disclosed
US-20090186927-A1 TRANS-9,10-DEHYDROEPOTHILONE C AND D, ANALOGS THEREOF AND METHODS OF MAKING THE SAME KOSAN BIOSCIENCES, INC. (US) 2009-07-23 US disclosed
EP-1562941-A2 TRANS-9,10-DEHYDROEPOTHILONE C AND D, ANALOGS THEREOF AND METHOS OF MAKING THE SAME Kosan Biosciences, Inc. (US) 2005-08-17 EP disclosed
US-20040152708-A1 Trans-9,10-dehydroepothilone C and D, analogs thereof and methods of making the same KOSAN BIOSCIENCES, INC. 2004-08-05 US disclosed
WO-2004043954-A2 TRANS-9,10-DEHYDROEPOTHILONE C AND D, ANALOGS THEREOF AND METHOS OF MAKING THE SAME KOSAN BIOSCIENCES INCORPORATED (US) 2004-05-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112149-A1 EPOTHILONE ANALOGUES, THEIR PHARMACEUTICAL COMPOSITIONS, THEIR USE AND THEIR PREPA RATIONS PPIA, PREP, THPO BDKRB2 1927/4885GRIN2D 4217/4885GRIN3B 4663/4885
US-20040152708-A1 Trans-9,10-dehydroepothilone C and D, analogs thereof and methods of making the same TMSB10, TUBA1C, TUBB1 BDKRB2 3323/4885GRIN2D 4282/4885GRIN3B 4568/4885
US-20090186927-A1 TRANS-9,10-DEHYDROEPOTHILONE C AND D, ANALOGS THEREOF AND METHODS OF MAKING THE SAME TMSB10, TUBA1C, TUBB1 BDKRB2 3323/4885GRIN2D 4282/4885GRIN3B 4568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.